Evidence map›Paper›PMID 32790123›Full record

ArticleChembiochem : a European journal of chemical biology2021

Using Mutability Landscapes To Guide Enzyme Thermostabilization.

Chao Guo, Yan Ni, Lieuwe Biewenga, Tjaard Pijning, Andy-Mark W H Thunnissen, Gerrit J Poelarends

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Learning Strategies in Protein Directed Evolution.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  5. Using Mutability Landscapes To Guide Enzyme Thermostabilization.Chembiochem : a European journal of chemical biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chao GuoDepartment of Chemical and Pharmaceutical Biology Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen (The, Netherlands.
Yan NiDepartment of Chemical and Pharmaceutical Biology Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen (The, Netherlands.
Lieuwe BiewengaDepartment of Chemical and Pharmaceutical Biology Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen (The, Netherlands.
Tjaard PijningStructural Biology Group, Groningen Institute of Biomolecular Sciences and Biotechnology, University of Groningen, Nijenborgh 7, 9747 AG, Groningen (The, Netherlands.
Andy-Mark W H ThunnissenMolecular Enzymology Group Groningen Institute of Biomolecular Sciences and Biotechnology, University of Groningen, Nijenborgh 4, 9747 AG, Groningen (The, Netherlands.
Gerrit J PoelarendsDepartment of Chemical and Pharmaceutical Biology Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen (The, Netherlands.ORCID 0000-0002-6917-6368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thermostabilizing enzymes while retaining their activity and enantioselectivity for applied biocatalysis is an important topic in protein engineering. Rational and computational design strategies as well as directed evolution have been used successfully to thermostabilize enzymes. Herein, we describe an alternative mutability-landscape approach that identified three single mutations (R11Y, R11I and A33D) within the enzyme 4-oxalocrotonate tautomerase (4-OT), which has potential as a biocatalyst for pharmaceutical synthesis, that gave rise to significant increases in apparent melting temperature T

Indexed as

TemperatureEnzyme StabilityIsomerasesMutationProtein Engineering4-oxalocrotonate tautomeraseIsomerasesbiocatalysismutability landscapeprotein engineeringthermostability

Identifiers

PMID32790123
PMCPMC7821111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.